Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Véronique Keppenne

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Revue Medicale De Liege|June 23, 2023
[The overactive bladder syndrome]Thomas Verjans, Manon Dewandre, Véronique Keppenne, et al.
The French Journal of Urology|March 5, 2026
Long-Term Adherence and Effectiveness of Intradetrusor Botulinum Toxin in Patients with Multiple SclerosisFlorian Patigny, Héléna Cassol, Bérangère Maillard, et al.
The French Journal of Urology|September 7, 2024
Clean intermittent catheterization in multiple sclerosis patients: An adherence and long-term follow-up studyBérengère Maillard, Hélena Cassol, Justine Slomian, et al.
Advances in Therapy|September 28, 2013
OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiologyDavid Ginsberg, Francisco Cruz, Sender Herschorn, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Revue Medicale De Liege|June 23, 2023
[The overactive bladder syndrome]Thomas Verjans, Manon Dewandre, Véronique Keppenne, et al.
The French Journal of Urology|March 5, 2026
Long-Term Adherence and Effectiveness of Intradetrusor Botulinum Toxin in Patients with Multiple SclerosisFlorian Patigny, Héléna Cassol, Bérangère Maillard, et al.
The French Journal of Urology|September 7, 2024
Clean intermittent catheterization in multiple sclerosis patients: An adherence and long-term follow-up studyBérengère Maillard, Hélena Cassol, Justine Slomian, et al.
Advances in Therapy|September 28, 2013
OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiologyDavid Ginsberg, Francisco Cruz, Sender Herschorn, et al.
Pageof 1